Please login to the form below
Norway
This page shows the latest Norway news and features for those working in and with pharma, biotech and healthcare.
Gavi says 76 wealthy countries have committed to COVAX vaccine facility
According to Berkley, over 70 nations have now signed up to the facility, including Japan, Norway and Germany, to procure vaccines through the COVAX facility for their respective nations.
Latest news
-
EU aims to vaccinate 40% of population in initial COVID-19 blueprint
health experts from a number of EU members states, Britain, Switzerland, Norway and the Balkans.
-
CEPI says $2bn is needed for COVID-19 vaccine development
The German government’s Federal Ministry of Education and Research has already provided £157m to support CEPI’s development of a COVID-19 vaccine, joining the governments of Norway and the
-
IQVIA and partners set up cancer ‘data hub’ to speed up research
The study showed that the UK performed worse than Australia, Canada, Denmark, Ireland, New Zealand and Norway in terms of cancer survival rates. .
-
New efficacy data boosts Aimovig’s migraine market lead
The data will be presented at the European Academy of Neurology's (EAN) annual meeting in Oslo, Norway.
-
Resurgent Diurnal raises £5.4m for twin product filings
In March, Diurnal also signed its first partnership for Alkindi with Swedish group Anthrop Pharmaceuticals, which covers the commercialisation of the drug in Sweden, Norway, Denmark, Finland and Iceland, a
More from news
Approximately 1 fully matching, plus 127 partially matching documents found.
Latest Intelligence
-
Developing a COVID-19 vaccine
The Coalition for Epidemic Preparedness Innovations (CEPI), an Oslo, Norway-based nonprofit, is helping to coordinate the development of a COVID-19 vaccine and is leading the efforts to finance the
-
Will biosimilars ever catch on in the US?
Notably the biosimilar Renflexis (infliximab-abda) achieved a 70-80% price reduction to its reference product in both Norway and Denmark.
-
The case for a second Brexit referendum: “We need the informed consent of the people”
As many in the pharma industry know, the EEA allows Norway, Iceland and Liechtenstein to be part of the EMA and gain access to the new medicines at the same time.
-
The tipping point
National policy mandates to switch from the originator to biosimilars, as has been the case in Norway, have resulted in rapid and almost complete biosimilar market penetration.
-
Building a bright future
We have many examples where small molecule and biosimilars have improved uptake such as the case of infliximab in Norway, which was supported by the government that sponsored clinical trials showing
More from intelligence
Approximately 0 fully matching, plus 17 partially matching documents found.
Latest appointments
-
Gilead Sciences appoints general manager, Canada
Brysting was most recently general manager of Gilead Nordics, comprising the company's businesses in Sweden, Norway, Denmark, Finland and Iceland.
-
Targovax appoints chief financial officer
Dr Wiklund joins the Oslo, Norway-based immuno-oncology specialist from Aker Biomarine Antarctic, where he served as director of product innovation.
-
Algeta execs join Targovax
Anna-Kirsti Aksnes and Tina Madsen join the firm. Norway's Targovax has added to its senior team with the appointment of two executives from Algeta.
-
Anker Lundemose appointed CEO of Bionor Pharma
The Norway-based biotech, which is focused on peptide-based vaccines for HIV, said Dr Lundemose will take over the role from March 1, when his predecessor Steen Krøyer becomes deputy
-
Matt Regan named AbbVie’s general manager in UK
Was formerly general manager of Abbott in Norway. AbbVie, the new independent biopharma spin-out from Abbott, has appointed Matt Regan as general manager of its UK business. ... Regan was formerly general manager for Abbott in Norway and will now oversee
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Lilly’s Verzenio scores a win in early-stage breast cancer
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- Novacyt launches diagnostic test to differentiate between COVID-19 and flu
- Keytruda doubles five-year survival rate in NSCLC
- FDA approves Roche’s Actemra COVID-19 trial
PMHub
Valid Insight
Valid Insight is an award-winning pharmaceutical global market access consultancy....
Latest intelligence
- Switzerland: a life sciences hub
- Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
- Responding to dynamic shifts in value communications
- OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
- Doing what we can and having fun doing it: our fundraising month
- Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...
Quick links
Infographics
